Strictly guard against the epidemic, build a strong anti-epidemic defense line, and further implement the epidemic prevention and control work in the logistics park.
Release time:
2021-08-11
News 8# February , peak international trading company convened the park tenants, construction unit representatives, security company personnel to hold a park epidemic prevention and control work meeting, in view of the current stage of the spread of the epidemic in China and the actual situation of the logistics park, the park put forward new epidemic prevention and control requirements.
Nanjing City, Jiangsu Province has spilled over to other cities and provinces in Jiangsu Province since the outbreak of Lukou International Airport was reported on 7# September 20 . The virus is traced back to Delta (Delta ) variant strain. This round of epidemic has the characteristics of strong infectivity and fast spread. Zhejiang Province and Nanjing and other epidemic-related cities have close economic and trade, personnel exchanges, the risk of epidemic import is high, the epidemic prevention and control situation is grim. Every day in the peak international trade logistics park, goods, vehicles and people from all over the country come and go, the epidemic prevention and control work is more complex, in order to effectively implement the epidemic prevention and control, peak international trade held this special meeting. At the
meeting, the relevant personnel of the park conveyed the relevant requirements of the provincial, municipal, district and township governments for the prevention and control of the current epidemic, and the tenants, construction units, the operation supervisor of the peak international trade warehouse, the director of the park, the security representative, etc. introduced the prevention and control measures and situation of the epidemic at this stage. The meeting on the peak international trade, especially the logistics park, from the control of access, plug loopholes, catch prevention, do a good job in the emergency plan four aspects of the epidemic prevention work requirements.On the basis of the normalization of epidemic prevention and control, Jianfeng International Trade Logistics Park will carry out stricter access management, measuring body temperature, health codes, wearing masks and communication big data travel cards, and handling park permits to enter the park after passing the examination. Close the temporary entrances and exits set up during the construction period, and all personnel will enter and leave the park through the prescribed gates. Disinfection in the park is carried out twice a day by a special person; vehicles should be killed before entering the park. Special isolation rooms will be set up at the gate guard, and relevant information of the epidemic prevention and control leading group will be made into billboards and placed in prominent positions. At the same time, in order to implement the main responsibility and do a good job in the supervision of epidemic prevention and control of tenants and construction parties, Jianfeng International Trade signed a letter of responsibility for epidemic prevention and control with all tenants. Hang relevant banners in the park, strengthen inspection in the park, and further do a good job in publicity in the park. Changes in personnel in the park are reported once a day. In addition to reporting to the local direct management department, tenants and construction also to the park to establish a punishment mechanism.
For self-operated storage business, Jianfeng International Trade Co., Ltd. communicated with the pick-up party in advance and requested to issue relevant information before entering the park to pick up the goods. For the import business, a special person is responsible for setting up an epidemic prevention warehouse for imported goods, and a sign is set up at the entrance of the warehouse. Irrelevant personnel are not allowed to enter the warehouse. Operators should be protected and killed throughout the epidemic prevention and control process, if you need to travel, you must report to the company. After telephone communication, the customer entrusts the inventory once a month through video monitoring.
(Reporter
Ni Yingzhen)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31